Global Pharmacovigilance and Drug Safety Software Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	145 Pages	TechNavio	August, 2024	INF19287123

Best Price Guarantee
Price	from $2,500
Length	145 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19287123

Global Pharmacovigilance And Drug Safety Software Market 2024-2028

The pharmacovigilance and drug safety software market is forecasted to grow by USD 69.1 million during 2023-2028, accelerating at a CAGR of 6.81% during the forecast period. The report on the pharmacovigilance and drug safety software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars.

Technavio's pharmacovigilance and drug safety software market is segmented as below:

By End-user
Pharmaceutical and biotechnology companies
Contract research organization
Business process outsourcing
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of ai in pharmacovigilance as one of the prime reasons driving the pharmacovigilance and drug safety software market growth during the next few years. Also, outsourcing pharmacovigilance and drug safety research to contract research organization (cros) and extensive adoption of cloud technologies in pharmaceutical manufacturing and testing will lead to sizable demand in the market.

The report on the pharmacovigilance and drug safety software market covers the following areas:

Pharmacovigilance and drug safety software market sizing
Pharmacovigilance and drug safety software market forecast
Pharmacovigilance and drug safety software market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software market vendors that include AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov SAS, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd.. Also, the pharmacovigilance and drug safety software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022; Historic Market Size - Data Table on Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028; Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); 6.4 Contract research organization - Market size and forecast 2023-2028; Chart on Contract research organization - Market size and forecast 2023-2028 ($ million); Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million); Chart on Contract research organization - Year-over-year growth 2023-2028 (%); Data Table on Contract research organization - Year-over-year growth 2023-2028 (%); 6.5 Business process outsourcing - Market size and forecast 2023-2028; Chart on Business process outsourcing - Market size and forecast 2023-2028 ($ million); Data Table on Business process outsourcing - Market size and forecast 2023-2028 ($ million); Chart on Business process outsourcing - Year-over-year growth 2023-2028 (%); Data Table on Business process outsourcing - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Customer Landscape: 7.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 8.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 8.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 8.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 8.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 8.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 8.8 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 8.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 8.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 8.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 8.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 AB Cube SARL; AB Cube SARL - Overview; AB Cube SARL - Product / Service; AB Cube SARL - Key offerings; 11.4 ArisGlobal LLC; ArisGlobal LLC - Overview; ArisGlobal LLC - Product / Service; ArisGlobal LLC - Key offerings; 11.5 BaseCon AS; BaseCon AS - Overview; BaseCon AS - Product / Service; BaseCon AS - Key offerings; 11.6 Ennov SAS; Ennov SAS - Overview; Ennov SAS - Product / Service; Ennov SAS - Key offerings; 11.7 EXTEDO GmbH; EXTEDO GmbH - Overview; EXTEDO GmbH - Product / Service; EXTEDO GmbH - Key news; EXTEDO GmbH - Key offerings; 11.8 Honeywell International Inc.; Honeywell International Inc. - Overview; Honeywell International Inc. - Business segments; Honeywell International Inc. - Key news; Honeywell International Inc. - Key offerings; Honeywell International Inc. - Segment focus; 11.9 Indegene Pvt. Ltd.; Indegene Pvt. Ltd. - Overview; Indegene Pvt. Ltd. - Product / Service; Indegene Pvt. Ltd. - Key offerings; 11.10 Oracle Corp.; Oracle Corp. - Overview; Oracle Corp. - Business segments; Oracle Corp. - Key news; Oracle Corp. - Key offerings; Oracle Corp. - Segment focus; 11.11 Sarjen Systems Pvt. Ltd.; Sarjen Systems Pvt. Ltd. - Overview; Sarjen Systems Pvt. Ltd. - Product / Service; Sarjen Systems Pvt. Ltd. - Key offerings; 11.12 United BioSource LLC; United BioSource LLC - Overview; United BioSource LLC - Product / Service; United BioSource LLC - Key offerings
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 12.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Parent Market; Exhibits10: Data Table on - Parent Market; Exhibits11: Market characteristics analysis; Exhibits12: Value Chain Analysis; Exhibits13: Offerings of companies included in the market definition; Exhibits14: Market segments; Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Historic Market Size - Data Table on Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022 ($ million); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Contract research organization - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Business process outsourcing - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Business process outsourcing - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Business process outsourcing - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Business process outsourcing - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits51: Chart on Geographic comparison; Exhibits52: Data Table on Geographic comparison; Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits89: Market opportunity By Geographical Landscape ($ million); Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits91: Impact of drivers and challenges in 2023 and 2028; Exhibits92: Overview on criticality of inputs and factors of differentiation; Exhibits93: Overview on factors of disruption; Exhibits94: Impact of key risks on business; Exhibits95: Companies covered; Exhibits96: Matrix on companies position and classification; Exhibits97: AB Cube SARL - Overview; Exhibits98: AB Cube SARL - Product / Service; Exhibits99: AB Cube SARL - Key offerings; Exhibits100: ArisGlobal LLC - Overview; Exhibits101: ArisGlobal LLC - Product / Service; Exhibits102: ArisGlobal LLC - Key offerings; Exhibits103: BaseCon AS - Overview; Exhibits104: BaseCon AS - Product / Service; Exhibits105: BaseCon AS - Key offerings; Exhibits106: Ennov SAS - Overview; Exhibits107: Ennov SAS - Product / Service; Exhibits108: Ennov SAS - Key offerings; Exhibits109: EXTEDO GmbH - Overview; Exhibits110: EXTEDO GmbH - Product / Service; Exhibits111: EXTEDO GmbH - Key news; Exhibits112: EXTEDO GmbH - Key offerings; Exhibits113: Honeywell International Inc. - Overview; Exhibits114: Honeywell International Inc. - Business segments; Exhibits115: Honeywell International Inc. - Key news; Exhibits116: Honeywell International Inc. - Key offerings; Exhibits117: Honeywell International Inc. - Segment focus; Exhibits118: Indegene Pvt. Ltd. - Overview; Exhibits119: Indegene Pvt. Ltd. - Product / Service; Exhibits120: Indegene Pvt. Ltd. - Key offerings; Exhibits121: Oracle Corp. - Overview; Exhibits122: Oracle Corp. - Business segments; Exhibits123: Oracle Corp. - Key news; Exhibits124: Oracle Corp. - Key offerings; Exhibits125: Oracle Corp. - Segment focus; Exhibits126: Sarjen Systems Pvt. Ltd. - Overview; Exhibits127: Sarjen Systems Pvt. Ltd. - Product / Service; Exhibits128: Sarjen Systems Pvt. Ltd. - Key offerings; Exhibits129: United BioSource LLC - Overview; Exhibits130: United BioSource LLC - Product / Service; Exhibits131: United BioSource LLC - Key offerings; Exhibits132: Inclusions checklist; Exhibits133: Exclusions checklist; Exhibits134: Currency conversion rates for US$; Exhibits135: Research methodology; Exhibits136: Information sources; Exhibits137: Data validation; Exhibits138: Validation techniques employed for market sizing; Exhibits139: Data synthesis; Exhibits140: 360 degree market analysis; Exhibits141: List of abbreviations